Confusion surrounding prostate cancer screening

The USPSTF recently updated their cancer screening guidelines, recommending against prostate cancer screening in men older than 75.

Toni Brayer recaps the controversy surrounding the PSA test. With a Democratic-controlled government, a push is going to be made for a comparative effectiveness institute. There is a real possibility that the dogma of “more screening equals better medicine” will be challenged.

Patients are going to face the repercussions of evidence-based medicine, which means the denial of scores of unproven tests that patients are receiving today.

topics: cancer screening, comparative effectiveness

View 1 Comments >

Most Popular

Get KevinMD's 5 most popular stories.